Home
About
FAQ
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Pardee, Timothy
One or more keywords matched the following items that are connected to
Pardee, Timothy
Item Type
Name
Concept
Pancreatic Neoplasms
Concept
Lung Neoplasms
Concept
Hematologic Neoplasms
Concept
Neoplasms
Academic Article
Animal models of leukemia: any closer to the real thing?
Academic Article
A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies.
Academic Article
Improving nucleoside analogs via lipid conjugation: Is fatter any better?
Academic Article
The applications of the novel polymeric fluoropyrimidine F10 in cancer treatment: current evidence.
Academic Article
A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma.
Grant
Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia
Grant
Metabolic contribution to cell viability and therapy resistance in the acute
Academic Article
Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial.
Academic Article
A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia.
Academic Article
Mitochondria in cancer metabolism, an organelle whose time has come?
Academic Article
Association between glycemic control, age, and outcomes among intensively treated patients with acute myeloid leukemia.
Grant
Translational Oncology Training Program
Academic Article
The prognostic value of standardized phase angle in adults with acute leukemia: A prospective study.
Academic Article
A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas.
Search Criteria
Cancer
metabolism